NBIX

NASDAQ

Neurocrine Biosciences, Inc. · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$15.93B

PE Ratio

28.2094

EV to Ebitda

18.3105

Earnings Yield

3.54%

Revenue (TTM)

$2.86B

Net Income (TTM)

$478.6M

Revenue (Annual YoY Growth)

21.45%

Revenue (Quarterly YoY Growth)

28.33%

Profit Margin

16.73%

Return on Equity

17.00%

Debt to Equity Ratio

0.1449

Dividend Yield

0.00%

All fundamentals

Core11 fields›

Market Cap$15.93B

Revenue TTM$2.86B

Shares Outstanding100.4M

Float96918513

Float Short5.40%

Days To Cover4.8618141787

Short Interest5363591.0

Insider Ownership7.54%

Volume597124

Relative Strength73.7

GARP1463

Growth Estimates17 fields›

Revenue Growth (Annual)21.45%

Revenue Growth (Quarterly YoY)28.33%

Operating Revenue Growth (Annual)0.244785

Operating Revenue Growth (Quarterly YoY)0.276071

3-Year Revenue Growth24.32%

5-Year Revenue Growth22.29%

EPS Growth (Annual)41.87%

EPS Growth (Quarterly YoY)47.94%

3-Year EPS Growth Rate44.05%

5-Year EPS Growth Rate2.31%

LT EPS Growth Estimates33.41%

EBITDA Growth (Annual)6.81%

EBITDA Growth (Quarterly YoY)54.77%

CFO Growth (Annual)31.46%

CFO Growth (Quarterly YoY)60.16%

FCF Growth (Annual)34.37%

FCF Growth (Quarterly YoY)66.16%

Operations28 fields›

Revenue TTM$2.86B

Gross Margin TTM98.18%

Gross Margin (Quarterly)97.81%

R&D % of Revenue TTM35.51%

R&D Expenses TTM$1.02B

Operating Margin TTM22.25%

Operating Margin (Quarterly)28.29%

Operating Expenses TTM$2.17B

Profit Margin TTM16.73%

Profit Margin (Quarterly)19.08%

Net Income TTM$478.6M

EPS TTM4.6676

EPS (Quarterly)1.4822

EBIT Margin TTM22.25%

EBIT Margin (Quarterly)28.29%

EBITDA Margin TTM23.30%

EBITDA Margin (Quarterly)29.22%

EBITDA TTM$666.6M

CFO % of Revenue TTM27.36%

CFO % of Revenue (Quarterly)48.22%

CFO TTM$782.7M

Cash Margin27.22%

Capex % of Revenue TTM1.19%

Capital Expenditures$34.0M

FCF % of Revenue TTM26.17%

FCF % of Revenue (Quarterly)48.52%

FCF TTM$748.7M

Fundamental Score7

Efficiency6 fields›

ROE17.00%

ROA11.71%

ROIC14.50%

CROCI22.68%

Stock Comp % (Quarterly)7.27%

Stock Comp % TTM7.62%

Valuation21 fields›

P/E (TTM)28.2094

P/E Forward14.0614

P/E Ex-Cash25.0492

P/S Forward3.6153

PEG0.6743

PEG Forward0.1399

P/CFO17.2305

P/FCF18.013

EV/EBITDA (TTM)18.3105

EV/EBITDA Forward13.6362

EV/Revenues (TTM)4.267

EV/Revenues Forward3.3392

EV/CFO16.8495

EV/FCF (TTM)16.3026

Price To Book4.0622

Price to Tangible Book5.9211

Earnings Yield3.54%

FCF Yield5.55%

Dividend Yield0.00%

Payout Ratio0.00%

Value Score3

Relative to Industry11 fields›

Relative Gross Margin (Quarterly)1.797

Relative Profit Margin (Quarterly)3.5526

Relative P/E1.4197

Relative P/S2.0838

Relative P/B1.6463

Relative Earnings Yield0.7044

Relative Dividend Yield0

Relative ROE1.2301

Relative ROA2.0695

Relative ROIC1.9098

Relative Debt to Equity0.2314

Liquidity14 fields›

Cash Per Share14.7892

Current Ratio3.3935

Cash & ST Assets$1.48B

Total Debt$415.3M

Goodwill & Intangibles$0.00M

Total Assets$4.75B

Total Liabilities$1.50B

Shareholders Equity$3.25B

Debt to Equity0.1449

Debt to Assets9.92%

Interest Expense$0.00M

CFO to Debt (TTM)1.6108

Debt to EBITDA (TTM)0.729

Goodwill % of Assets0.00%

Yields5 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield3.54%

Buyback Yield0.29%

Shareholder Yield0.01%

Options Flow8 fields›

Call Volume723

Put Volume306

Put/Call Ratio0.42323651452282157

Call $ Volume2704434

Put $ Volume109877

Put/Call $ Ratio0.04062846421839098

Call OI7450

Put OI6485